Prospective randomized controlled trial of combination ranibizumab (lucentis) and bromfenac (xibrom) for neovascular age-related macular degeneration: A pilot study

Christina Flaxel, Mitchell B. Schain, Sara C. Hamon, Peter J. Francis

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective randomized controlled trial of combination ranibizumab (lucentis) and bromfenac (xibrom) for neovascular age-related macular degeneration: A pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences